|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Preclinical studies of desloratadine, a non-sedating, selective histamine HI receptor antagonist with antiallergic activity显示文摘 | Kreutner W Hey JA Authes J | 2000 | Allergy2000，55，1： | 1 |
| 2 | Preclinical pharmacology of desloratadinea selective and non-sedating histamine H1 receptor antagonist显示文摘 | Kreutner W Hey JA Bamett A | | 0，，： | 1 |
| 3 | Organization of cell walls in Sandersonia aurantiaca floral tissue显示文摘 | O’DONOGHUE EM SOMERFIELD SD HEYES JA | 2002 | Experimental Botany2002，53，368： | 1 |
| 4 | Glioma oncoprotein BcI2L12 inhibits the p53 tumor suppressor显示文摘 | Stegh AH Breunan C Maho hey JA | 2010 | Genes Dev2010，124，19： | 1 |
| 5 | Capsaicin exposure elicitscomplex airway defensive motor patterns in normal humans ina concentration-dependent manner 显示文摘 | Vovk A Bolser DC Hey JA | 2007 | Pulm Pharmacol Ther2007，20，4： | 1 |
| 6 | A model of allergic nasal congestion in dogs sensitized to ragweed 显示文摘 | Rudolph K Bice DE Hey JA | 2003 | Am J Rhinol2003，17，4： | 1 |
| 7 | Preclinical pharmacology of desloratadine, a slective and nonsedating histamine H1 receptor antagonist: 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects 显示文摘 | Kreutner W Hey JA Anthes J | | Arzneimittelfo0，，： | 1 |
| 8 | Comparative analysis of the cardiotoxicity proelivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects显示文摘 | Hey JA Del Prado M Sherwood J | 1996 | Arzneittetforschung1996，46，： | 1 |
| 9 | Histamine H3 receptor activation inhibits neurogenic sympathetic vasoconstriction in porcine nasal mucosa显示文摘 | Varty LM Gustafson E Hey JA | 2002 | Eur J Pharmacol2002，452，： | 1 |
| 10 | Preclinical studies of desloratadine, a non-sedating, selective histamine H1 receptor antagonist with antiallergic activity显示文摘 | Hey JA Anthes J | 2000 | Allergy2000，55，63： | 1 |
| 11 | Plasma membrane ATPase activity during pepino (Splanum muricatun) ripening显示文摘 | Heyes JA Sealey DF Vre de LA 1997 | 1997 | Physiol Plant1997，101，： | 1 |
| 12 | Identification of a Caenorhabdi-tis elegans Δ6 fatty acid-desaturase by heterologous expression in Saccharomyces cereviciae 显示文摘 | Napier JA Hey SJ Lacey DJ | 1998 | Biochem1998，330，： | 1 |
| 13 | Preclinical effica-cy and antiallergic profile of desloratadine, a selectiveand nonsedating histamine H1 receptor antagonist显示文摘 | Hey JA Anthes J | 2000 | J Allergy Clin Immunol2000，105，12： | 1 |
| 14 | Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1receptor antagonist 显示文摘 | Hey JA Anthes J | 2000 | Arzneimittelforschung2000，50，4： | 1 |
| 15 | Preclinical pharmacol-ogy of desloratadine,a selective and nonsedating histamine H1 receptor antihistaminic activity,and antiallergenic effects显示文摘 | Kreuner W Hey JA Anthes J | 2000 | Arzneimittlfors-chung2000，50，： | 1 |
| 16 | (R)-alpha-methylhistamine augments neural,cholinergic bronchospasm in guinea pigs by histamine H1 receptor activation显示文摘 | Hey JA del Prado M Egan RW | 1992 | Eur J Pharmacol1992，211，： | 1 |
| 17 | Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist显示文摘 | Kreutner W Hey JA Chiu P | 2000 | Arzneim-Forsch/Drug Res2000，50，1： | 1 |
| 18 | The quinea pig model for assessing cardiotoxic proctivities of second generation antihistamines显示文摘 | del Prado M Sherwood J | 1996 | Arzneimttelforschung1996，46，： | 1 |
| 19 | Preclinical pharmacology of deslo -ratidine ,a selective and nonsedating histramine H I receptor antagonist Ist communication, receptor selectivity, antihistaminic activity and antial-lergnie effects 显示文摘 | Kreutner W Hey JA Anthes J | 2000 | Arzneimittelforsehung2000，50，4： | 1 |
| 20 | Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects显示文摘 | Hey JA Del Prado M Sherwood J | 1996 | Arzneimittelforschung1996，46，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员